CERo Therapeutics (CERO)

• Market cap: $4.01M
• 1 day: 0.6%
• 5 days: -38.33%
• 1 month: -38.67%
• 3 months: -61.59%
• 6 months: -75.19%
• Year to date: -97.27%
• 1 year: -98.31%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Employees: 8